Expand IPHA Menu
IPHA MENU

IPHA Latest Press Releases

-- December 9, 2024 --

Innate Pharma Presents Lacutamab Improved Health-related Quality of Life Data at ASH 2024 From TELLOMAK Phase 2 Study in Patients With Cutaneous T Cell Lymphoma Business Wire 1:00 AM

-- December 6, 2024 --

Innate Pharma and the Institute for Follicular Lymphoma Innovation (IFLI) Announce up to $7.9M Investment From IFLI to Support IPH6501 Development in Follicular Lymphoma Business Wire 1:00 AM

-- December 3, 2024 --

Innate Pharma Highlights Abstracts Selected for the ASH Annual Meeting 2024 Business Wire 1:00 AM

-- November 20, 2024 --

Innate Pharma Releases Its 2025 Financial Calendar Business Wire 1:00 AM

-- November 19, 2024 --

Innate Pharma Announces Publication in Science Immunology Highlighting Innovative Next-generation ANKET IPH6501 Business Wire 1:00 AM

-- November 13, 2024 --

Innate Pharma Reports Third Quarter 2024 Business Update and Financial Results Business Wire 1:00 AM

-- November 8, 2024 --

Innate Pharma Highlights Data From Its Innovative Oncology Portfolio Selected for the SITC Annual Meeting 2024 Business Wire 1:00 AM

-- November 7, 2024 --

Innate Pharma Announces Conference Call and Webcast for Third Quarter 2024 Results and Business Updates Business Wire 1:00 AM

-- October 14, 2024 --

Innate Pharma Appoints Jonathan Dickinson as New Chief Executive Officer and Chairman of the Executive Board Business Wire 1:00 AM

-- September 30, 2024 --

Innate Pharma to Host KOL Scientific Symposium on Immunotherapy in New York on October 3, 2024 Business Wire 1:00 AM

-- September 23, 2024 --

Innate Pharma Announces FDA Clearance of the IND for IPH4502, a Nectin-4 ADC to Be Developed in Solid Tumors Business Wire 1:00 AM

-- September 12, 2024 --

Innate Pharma Reports First Half 2024 Business Update and Financial Results Business Wire 1:00 AM

-- September 9, 2024 --

Innate Pharma SA: Monalizumab Data From NeoCOAST-2 Phase 2 Study in Early-Stage NSCLC Presented at the WCLC 2024 Business Wire 1:00 AM

-- September 5, 2024 --

Innate Pharma Announces Conference Call and Webcast for First Half 2024 Financial Results and Business Update Business Wire 1:00 AM

-- September 4, 2024 --

Innate Pharma Announces Its Participation in the H.C. Wainwright 26th Annual Global Investment Conference Business Wire 1:00 AM

-- August 1, 2024 --

Innate Pharma Announces Its Participation in Upcoming Investor Conference Business Wire 1:00 AM

-- July 25, 2024 --

Number of Shares and Voting Rights of Innate Pharma as of July 10, 2024 Business Wire 1:00 AM